Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Possible wrong schedule; Possible wrong schedule; This non-serious case was reported by a consumer via sales rep and described the occurrence of inappropriate schedule of drug administration in a patient who received Men B NVS (Bexsero) for prophylaxis. On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced inappropriate schedule of drug administration (Verbatim: Possible wrong schedule) and incomplete course of vaccination (Verbatim: Possible wrong schedule). The outcome of the inappropriate schedule of drug administration and incomplete course of vaccination were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-MAY-2025 The doctor was inquiring on why they don't need to bring back the patients if they gave them Bexsero at the 0-1 month when Bexsero has an accelerated dosing of 0-1-2 and 6 months which led to inappropriate schedule of drug administration and incomplete course of vaccination. She understood that the 0 1-2 6 is for specific patients however were those patients she gave 0-1 month protected since we have a 3 dose indication. The dosing schedule was confusing her. The Vaccine Administration Facility is the same as Primary Reporter No more information shared.